Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

424
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424
Clinical Trials01:16

Clinical Trials

10.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.8K
Comparative Excretory Systems02:24

Comparative Excretory Systems

26.7K
Animals have evolved different strategies for excretion, the removal of waste from the body. Most waste must be dissolved in water to be excreted, so an animal’s excretory strategy directly affects its water balance.
26.7K
C4 Pathway and CAM01:27

C4 Pathway and CAM

49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

18.8K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries.

European urology·2026
Same author

Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations.

JAMA oncology·2026
Same author

Prevention and treatment of incontinence-associated dermatitis through optimising care: the PREVENT-IAD Synopsis.

Health technology assessment (Winchester, England)·2026
Same author

Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in Sweden.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

National survey of urologists' views on prostate cancer screening in the United Kingdom.

BJUI compass·2026
Same author

Exploring undergraduate student perceptions of the appropriateness of standardized mental health screening measures: a qualitative descriptive study.

Journal of American college health : J of ACH·2026

Related Experiment Video

Updated: Feb 7, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.7K

Prostate Pathway Embedded Comparative Trial: Outcomes from the Pilot Phase of the Imperial Prostate 3-PROState

Edward James Bass1, Francesca Rawlins2, Taimur Shah1

  • 1Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK; Imperial Urology, Division of Cancer, Cardiovascular Medicine and Surgery, Imperial College Healthcare NHS Trust, London, UK.

European Urology Focus
|June 5, 2025
PubMed
Summary

The Imperial Prostate 3-PROState Pathway Embedded Comparative Trial (IP3-PROSPECT) found that a cohort multiple randomized controlled trial (cmRCT) design is feasible and acceptable for prostate cancer research. This innovative approach shows promise for future comparative effectiveness studies.

Keywords:
Clinical trialsCohort multiple randomised controlled trialProstate cancer

More Related Videos

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.6K
Handling and Assessment of Human Primary Prostate Organoid Culture
08:45

Handling and Assessment of Human Primary Prostate Organoid Culture

Published on: January 17, 2019

17.9K

Related Experiment Videos

Last Updated: Feb 7, 2026

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.7K
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
06:04

Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.

Published on: March 6, 2018

17.6K
Handling and Assessment of Human Primary Prostate Organoid Culture
08:45

Handling and Assessment of Human Primary Prostate Organoid Culture

Published on: January 17, 2019

17.9K

Area of Science:

  • Oncology
  • Clinical Trials
  • Health Services Research

Background:

  • Prostate cancer diagnosis and treatment are rapidly evolving, necessitating innovative clinical trial designs.
  • The Imperial Prostate 3-PROState Pathway Embedded Comparative Trial (IP3-PROSPECT) was initiated to address this need.

Purpose of the Study:

  • To explore the feasibility and acceptability of a cohort multiple randomized controlled trial (cmRCT) design within the prostate cancer clinical pathway.
  • To assess the potential advantages of cmRCT over traditional trial designs in prostate cancer research.

Main Methods:

  • Eligible participants with suspected prostate cancer were invited to join a cmRCT cohort, consenting to future randomizations.
  • Patient-reported outcome measure (PROM) questionnaires were administered at baseline and follow-up to capture patient experiences.
  • Recruitment occurred across four sites, approaching individuals at the point of referral.

Main Results:

  • IP3-PROSPECT recruited 139 participants, achieving an approach rate of 35.3%, demonstrating feasibility.
  • High completion rates for PROM questionnaires were observed, providing valuable patient insights.
  • Both participants and healthcare professionals viewed the cmRCT design favorably, recognizing its potential benefits.

Conclusions:

  • The IP3-PROSPECT study confirms the feasibility and acceptability of implementing a cmRCT design in the prostate cancer pathway.
  • Further research is warranted to evaluate the effectiveness of cmRCT in generating comparative effectiveness data for prostate cancer interventions.